ADXS : Insider Transactions for Advaxis Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Advaxis Inc (ADXS)

$0.06 0.00 (0.00%) as of 4:30 Fri 6/3

Download

Exchange:

OTC Bulletin Board

Security Type:

Common

Shares Out:

66,230,000

Market Cap:

4.11(M)

Last Volume:

362,100

Avg Vol:

361,099

52 Week Range:

$0.062 - $0.062

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Advaxis is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) Technology antigen delivery products based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. Co.'s pipeline of product candidates include: ADXS-503, which is for the cancer indication of non-small cell lung cancer in combination with KEYTRUDA® (pembrolizumab); ADXS-504, which is for the cancer indication of early stage prostate cancer; and ADXS-PSA, which is for the cancer indication of metastatic prostate cancer in combination with KEYTRUDA® (pembrolizumab).

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	1,317,716	1,317,716
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	1	1
Total Buy Transactions	0	0	1	1
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-15	2023-11-14	2023-05-16	2022-05-16

Adjust Filter Settings

Records found: 465

Page 13 of 19

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Chief Scientific Officer

• – –

2015-05-29

4

A

$25.16

$1,962

D/D

78

138,360

-

Mayes Gregory T.

Chief Operating Officer

• – –

2015-05-29

4

D

$25.16

$403

D/D

(16)

138,589

-

Mayes Gregory T.

Chief Operating Officer

• – –

2015-05-29

4

A

$25.16

$1,937

D/D

77

138,605

-

10% Owner

– – •

2015-04-30

4

B

$19.00

$9,500,000

I/I

500,000

5,639,366

1.5

-

Mayes Gregory T.

Chief Operating Officer

• – –

2015-04-30

4

D

$16.81

$370

D/D

(22)

138,528

-

Mayes Gregory T.

Chief Operating Officer

• – –

2015-04-30

4

A

$16.81

$1,832

D/D

109

138,550

-

Chief Financial Officer

• – –

2015-04-30

4

D

$16.81

$286

D/D

(17)

93,950

-

Chief Financial Officer

• – –

2015-04-30

4

A

$16.81

$1,547

D/D

92

93,967

-

Chief Medical Officer

• – –

2015-04-30

4

D

$16.81

$219

D/D

(13)

190,156

-

Chief Medical Officer

• – –

2015-04-30

4

A

$16.81

$1,278

D/D

76

190,169

-

O'connor Daniel

Chief Executive Officer

• – –

2015-04-30

4

A

$16.81

$6,943

D/D

413

357,766

-

Chief Scientific Officer

• – –

2015-04-30

4

D

$4.03

$10,936

D/D

(2,574)

138,282

-

Chief Scientific Officer

• – –

2015-04-30

4

A

$16.81

$1,950

D/D

116

138,326

-

Chief Scientific Officer

• – –

2015-03-31

4

D

$14.44

$260

D/D

(18)

140,740

-

Chief Scientific Officer

• – –

2015-03-31

4

A

$14.44

$1,949

D/D

135

140,758

-

Chief Medical Officer

• – –

2015-03-31

4

D

$14.44

$549

D/D

(38)

190,093

-

Chief Medical Officer

• – –

2015-03-31

4

A

$14.44

$1,227

D/D

85

190,131

-

Mayes Gregory T.

Chief Operating Officer

• – –

2015-03-31

4

D

$14.44

$202

D/D

(14)

138,441

-

Mayes Gregory T.

Chief Operating Officer

• – –

2015-03-31

4

A

$14.44

$1,617

D/D

112

138,455

-

O'connor Daniel

Chief Executive Officer

• – –

2015-03-31

4

A

$14.44

$6,657

D/D

461

357,353

-

Chief Financial Officer

• – –

2015-03-31

4

D

$14.44

$260

D/D

(18)

93,875

-

Chief Financial Officer

• – –

2015-03-31

4

A

$14.44

$1,372

D/D

95

93,893

-

Chief Scientific Officer

• – –

2015-03-30

4

A

$0.00

$0

D/D

31,092

140,623

-

Chief Medical Officer

• – –

2015-03-30

4

D

$13.44

$81,473

D/D

(6,062)

190,046

-

Chief Medical Officer

• – –

2015-03-30

4

A

$0.00

$0

D/D

55,110

196,108

-

465 Records found	Previous 10 11 12 13 14 15 16 17 18 19	Page 13 of 19

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.